KORU Medical Systems (NASDAQ:KRMD) Upgraded to Strong-Buy by B. Riley

B. Riley upgraded shares of KORU Medical Systems (NASDAQ:KRMD) to a strong-buy rating in a research note published on Wednesday morning, Zacks.com reports.

KORU Medical Systems Stock Down 2.9 %

KORU Medical Systems stock opened at $2.49 on Wednesday. The company has a quick ratio of 3.37, a current ratio of 4.01 and a debt-to-equity ratio of 0.02. KORU Medical Systems has a 12-month low of $1.98 and a 12-month high of $3.12. The firm’s fifty day moving average is $2.40 and its 200 day moving average is $2.26. The company has a market capitalization of $113.71 million, a PE ratio of -8.87 and a beta of 0.40.

KORU Medical Systems (NASDAQ:KRMD) last released its earnings results on Wednesday, May 1st. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.02. KORU Medical Systems had a negative net margin of 45.24% and a negative return on equity of 25.10%. The company had revenue of $8.20 million for the quarter, compared to the consensus estimate of $7.49 million. During the same quarter in the previous year, the company earned ($0.05) EPS. As a group, sell-side analysts predict that KORU Medical Systems will post -0.16 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. Bard Associates Inc. lifted its position in shares of KORU Medical Systems by 22.5% during the 4th quarter. Bard Associates Inc. now owns 26,710 shares of the company’s stock valued at $66,000 after acquiring an additional 4,910 shares during the period. Lakewood Asset Management LLC lifted its position in shares of KORU Medical Systems by 13.9% during the 2nd quarter. Lakewood Asset Management LLC now owns 68,225 shares of the company’s stock valued at $181,000 after acquiring an additional 8,300 shares during the period. Aaron Wealth Advisors LLC acquired a new position in shares of KORU Medical Systems during the 2nd quarter valued at $28,000. Mesirow Financial Investment Management Inc. acquired a new position in KORU Medical Systems during the first quarter worth $26,000. Finally, Advisor Resource Council acquired a new position in KORU Medical Systems during the first quarter worth $63,000. Institutional investors and hedge funds own 58.60% of the company’s stock.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.